CTI BioPharma prices $69M follow-on

Cancer company CTI BioPharma Corp. (NASDAQ:CTIC) raised $69 million through the sale of 20 million shares at $3 in a follow-on underwritten by Leerink Partners, JMP Securities, Needham and Oppenheime...